DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.


Understand the complete disease landscape and size global markets with real world data

  • Benchmark your forecasts with data on the total potential and addressable market
  • Validate your investments using bottom-up forecasting
  • Identify growth opportunities and understand how populations will change over time
  • Confidently estimate drug-treated populations with additional insights from therapeutic experts and primary market research


Schedule a demo


  • Coverage of 170+ diseases and biomarkers across 45 countries and 3,500+ patient segments
  • Transparent and validated bottom-up methods with proprietary models for exposure-based forecasting
  • Global coverage using validated models of epidemiological transition and geographical extrapolation
  • Estimates based on combinations of publicly available studies, disease registries, and in-house real world data

Only DRG’s Epidemiology forecasts at the total, diagnosed, and drug-treated levels – providing the complete market picture

The foundation for sizing market potential, profiling patient segments and informing confident forecast-based business decisions.

Total Population

The broadest actual – not extrapolated – geographic coverage and most granular population segments for oncology, rare and niche diseases, and beyond.